876 — Kaisa Health group Income Statement
0.000.00%
Last trade - 00:00- HK$105.88m
- -HK$50.44m
- HK$185.88m
Annual income statement for Kaisa Health group, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 252 | 184 | 210 | 191 | 186 |
| Cost of Revenue | |||||
| Gross Profit | 123 | 90 | 97.4 | 82.6 | 81.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 614 | 224 | 190 | 355 | 176 |
| Operating Profit | -362 | -40.4 | 19.4 | -163 | 9.72 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -363 | -41.5 | 11.2 | -171 | 6.05 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -355 | -40.7 | -12.3 | -172 | 6.15 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -355 | -39.7 | 2.36 | -123 | 7.47 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -355 | -39.7 | 2.36 | -123 | 7.47 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.024 | -0.008 | 0.001 | -0.015 | -0.007 |